PharmGen Science Inc Strategic Asset Allocation Index
PharmGen Science Inc strategic asset allocation index. PharmGen Science Inc (004720) has a Strategic Asset Allocation Index of 19.4% as of June 2023. Strategic assets (PP&E of ₩42.69 Billion plus long-term investments of ₩-) total ₩42.69 Billion, measured against net assets of ₩220.19 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 004720 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of PharmGen Science Inc (2004–2021)
Strategic asset allocation index of PharmGen Science Inc from 2004 to 2021. This chart shows how PharmGen Science Inc's Strategic Asset Allocation Index has evolved across 14 annual periods from 2004 to 2021. As of June 2023, the index stands at 19.4%, representing strategic assets of ₩42.69 Billion against net assets of ₩220.19 Billion KRW.
PharmGen Science Inc Strategic Asset Allocation Index by Year (2004–2021)
PharmGen Science Inc strategic asset allocation index by year from 2004 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for PharmGen Science Inc from 2004 to 2021, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 004720 company net worth.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 27.5% | ₩34.90 Billion | ₩34.90 Billion | ₩- | ₩126.93 Billion | ▲ +6.9 pp |
| 2020 | 20.6% | ₩17.21 Billion | ₩17.21 Billion | ₩- | ₩83.57 Billion | ▼ -7.1 pp |
| 2019 | 27.7% | ₩15.60 Billion | ₩15.60 Billion | ₩- | ₩56.25 Billion | ▲ +6.2 pp |
| 2018 | 21.5% | ₩12.21 Billion | ₩8.62 Billion | ₩3.60 Billion | ₩56.85 Billion | ▼ -0.8 pp |
| 2017 | 22.3% | ₩11.38 Billion | ₩8.84 Billion | ₩2.54 Billion | ₩51.05 Billion | ▼ -4.3 pp |
| 2016 | 26.5% | ₩9.66 Billion | ₩8.35 Billion | ₩1.32 Billion | ₩36.41 Billion | ▲ +2.3 pp |
| 2015 | 24.2% | ₩6.95 Billion | ₩5.95 Billion | ₩997.34 Million | ₩28.66 Billion | ▼ -8.8 pp |
| 2014 | 33.0% | ₩6.64 Billion | ₩5.94 Billion | ₩703.54 Million | ₩20.12 Billion | ▲ +3.9 pp |
| 2013 | 29.1% | ₩6.94 Billion | ₩6.42 Billion | ₩526.33 Million | ₩23.83 Billion | ▲ +1.6 pp |
| 2012 | 27.5% | ₩7.12 Billion | ₩7.12 Billion | ₩- | ₩25.90 Billion | ▼ -11.7 pp |
| 2011 | 39.2% | ₩7.32 Billion | ₩7.32 Billion | ₩- | ₩18.69 Billion | ▲ +28.6 pp |
| 2005 | 10.6% | ₩3.50 Billion | ₩3.50 Billion | ₩- | ₩33.07 Billion | ▼ -1.8 pp |
| 2004 | 12.4% | ₩3.08 Billion | ₩3.08 Billion | ₩- | ₩24.91 Billion | ▲ +0.3 pp |
| 2004 | 12.0% | ₩3.10 Billion | ₩3.10 Billion | ₩- | ₩25.73 Billion | — |